Skip to content

Clinical trials

Phase 2 Schizophrenia trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Phase: Phase 2 Country / region: Russia Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20072
20084
20095
20101
20112
20122
20131
20141
20162
20171
20202

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Denovo Biopharma LLC4
Otsuka Pharmaceutical Development & Commercialization, Inc.4
Hoffmann-La Roche3
Forest Laboratories2
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.2
ACADIA Pharmaceuticals Inc.1
AbbVie1
AbbVie (prior sponsor, Abbott)1
Amgen1
FORUM Pharmaceuticals Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia25
Central Nervous System Diseases1
Cognitive Dysfunction1
Mental Disorders1
Psychotic Disorders1
Recurrence1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.